Stay updated with breaking news from Cmab biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StreetInsider.com - Corporate News streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
WuXi Biologics a réalisé trois acquisitions pour renforcer son réseau mondial prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
MedCity News Arch Oncology adds $105M for better way to get immune cells to gobble up tumors Several companies are developing immunotherapies targeting the “don’t eat me” cancer protein CD47. Arch Oncology, which is developing drugs with features that could set them apart from this field, now has $105 million for multiple clinical trials. Shares0
The first wave of cancer drugs that clear the way for a certain immune cell to gobble up tumors has yet to reach the market, but Arch Oncology is already developing what it calls the “next-generation” of this type of cancer immunotherapy and it has raised $105 million in fresh capital to advance multiple clinical tests of its lead asset. ....